Upstate Active Clinical Trials

Study Title:

Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor: A Groupwide Phase III Study

What is the purpose of the study?

Treatment study to find ways to get rid of the tumor cells while saving the largest amount of normal kidney tissue possible.

Upstate Institutional Review Board (IRB) Number:

229453

Study/Protocol ID:

AREN0534

Study Phase:

N/A

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT00945009

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again